Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

发表于 2026-9-8 09:57:52

期刊：Nature Genetics

文献作者：Luana Calabrò; Francesca P. Caruso; Alessia Covre; Teresa M. R. Noviello; Maria F. Lofiego; Rossella Tufano; Luigi Ferraro; Piera Grisolia; Antonio De Falco; Vincenzo Lagano; Francesco Sgambelluri; Giovanna Sabella; Giulia Rossi; Giulia Gibilisco; Francesco Marzani; Emma Bello; Elena Simonetti; Vincenzo D’Alonzo; Michele Caraglia; Sandra Coral; Antonina De Angelis; Luigi Cerbone; Sara Delfanti; Diana Giannarelli; Federica Grosso; Anna Maria Di Giacomo; Massimo Milione; Roberta Mortarini; Andrea Anichini; Michele Ceccarelli; Michele Maio

出版日期：2026-5-

DOI号：10.1038/s41588-026-02580-4

下载链接：https://www.nature.com/articles/s41588-026-02580-4.pdf

文献链接：https://doi.org/10.1038/s41588-026-02580-4

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-9-8 09:57:53

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Nature] Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Nature] Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study 一键复制

已采纳